title: Premedication with IV steroids effectively prevented anaphylactic reactions following ferumoxytol given as IV push in hematology and oncology patients.
authors.affiliation: Department of Pharmacy, the Mount Sinai Hospital, New York, New York.
authors.forename: Kara
authors.initials: K
authors.lastname: Braaten
authors.affiliation: Division of Hematology/Oncology, Tisch Cancer Institute, the Mount Sinai Hospital, New York, New York.
authors.forename: Randall F
authors.initials: RF
authors.lastname: Holcombe
authors.affiliation: Department of Pharmacy, the Mount Sinai Hospital, New York, New York.
authors.forename: Sara S
authors.initials: SS
authors.lastname: Kim
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000707:Anaphylaxis / Q000139:chemically induced / Q000517:prevention & control; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D052203:Ferrosoferric Oxide / Q000008:administration & dosage / Q000009:adverse effects*; D005938:Glucocorticoids / Q000008:administration & dosage*; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D012189:Retrospective Studies
chemical_list: D005938:Glucocorticoids; D006397:Hematinics; D003907:Dexamethasone; D052203:Ferrosoferric Oxide